MyCEI Login


8th Annual New York State Sexual Health Conference: Directions, Perspectives, and Predictions Day 4


Published Date: 09/01/2022

Expiration Date: 06/06/2025

CE Credit: CME:1.5


The Predictions Panel: New Developments in Testing, Treatment, and Vaccines: In this presentation, Drs. Cameron, Dobrzynski, Jr., and Hay provide unique perspectives on the future of STI testing, treatment, and vaccines through a mix of didactic lecture and panel discussion. Presenters describe innovative STI diagnostic tests, discuss antibiotics in development with activity against bacterial STIs, and review potential vaccine candidates for STIs.


Andrew Cameron,PhD

Andrew Cameron, PhD is a faculty member in the Department of Pathology and Laboratory Medicine and is the assistant director of the Clinical Microbiology Laboratories at the UR Medicine Central Laboratory. As a board-certified clinical microbiologist, he is a Diplomate of the American Board of Medical Microbiology. Dr. Cameron completed his PhD at the University of British Columbia, Vancouver, and completed his post-doctoral training at the University of Calgary and the Government of Canada. He also completed a fellowship in Medical and Public Health Microbiology at the University of Rochester Medical Center. Dr. Cameron has over ten years of experience in microbiology research, and his research interests include whole-genome sequencing and comparative genomics of bacterial pathogens, and he currently is involved in whole-genome sequencing of SARS-CoV-2.

David Dobrzynski,MD

David Dobrzynski, MD received his Bachelor of Science in Biochemistry from Bucknell University and his Doctorate of Medicine from Albany Medical College. He completed his Internal Medicine Residency at Wake Forest Baptist Medical Center(WFBMC) in Winston-Salem, NC. He continued on as faculty at WFBMC as an Assistant Chief of Medicine for the following year. He then went on to complete his Infectious Diseases Fellowship at Vanderbilt University in Nashville, TN. He currently sees inpatients on the General Infectious Diseases consult service as well as outpatients in the general ID Clinic. He serves as Medical Director for the Antimicrobial Stewardship Program at Strong Memorial Hospital, and as the Program Director of the Infectious Diseases Fellowship at the University of Rochester Medical Center. His main clinical research interests include antimicrobial stewardship, multi-drug resistant organisms, and hospital-acquired infections. He remains active in teaching of fellows, residents, and medical students. 

Christine M Hay,MD

Christine M. Hay, MD is a Professor of Medicine in Infectious Diseases at and Associate Dean for Admissions at the University of Rochester School of Medicine and Dentistry. She received her medical degree from Washington University School of Medicine in St. Louis. Dr. Hay’s Residency & Fellowship in Infectious Disease was at Massachusetts General Hospital and she has been in practice for more than 20 years. Her main research focus has been HIV Clinical Trials and viral vaccines.

Learning Objectives

  • Identify strategies to improve sexual healthcare.
  • Discuss testing and treatment recommendations for sexually transmitted infections in pregnancy.
  • Identify trends in STI epidemiology in New York State with a focus on syphilis.

Continuing Education Credit Information